Metraipolis › archive › dc_f30e41caebf1

RNA therapeutics in rheumatoid arthritis, systemic lupus erythematosus, and systemic sclerosis: a compartment-aware translational framework — Europe PMC PMID:42899094

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42899094
DOI
10.3389/fimmu.2026.1950465
License (as archived)
solo-consultazione
Archived
2026-10-31T20:26:24.062Z
SHA-256 of the archived text
8b75b7121fc8f0aa5cecf58bfb4cf27fe5ff4d2abcc8d05b549765de79aa1a8b
Stable URL of this page
https://metraipolis.com/documento/dc_f30e41caebf1

How to cite

RNA therapeutics in rheumatoid arthritis, systemic lupus erythematosus, and systemic sclerosis: a compartment-aware translational framework — Europe PMC PMID:42899094 — Europe PMC (en), https://europepmc.org/article/MED/42899094 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f30e41caebf1 (Metraipolis archive dc_f30e41caebf1, sha256 8b75b7121fc8f0aa5cecf58bfb4cf27fe5ff4d2abcc8d05b549765de79aa1a8b)
BibTeX
@misc{dcf30e41caebf1,
  title = {RNA therapeutics in rheumatoid arthritis, systemic lupus erythematosus, and systemic sclerosis: a compartment-aware translational framework — Europe PMC PMID:42899094},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42899094},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f30e41caebf1; sha256 8b75b7121fc8f0aa5cecf58bfb4cf27fe5ff4d2abcc8d05b549765de79aa1a8b},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42899094. Agents can read the archived copy with the MCP tool read_document.